Novartis Österreich überzeugte als forschendes und heimisch produzierendes Pharmaunternehmen mit den drei Standorten Wien, Kundl und Schaftenau in allen Kategorien Besonders punktete Novartis in den ...
Un 62% de las entidades de pacientes coinciden en que la profesionalización de sus organizaciones es uno de los principales retos a los que se enfrentan. Un hecho que impacta, según estas entidades, ...
Ontario is the first province in Canada to offer public reimbursement for Pluvicto™, a targeted radioligand therapy for patients with progressive PSMA-positive metastatic castration-resistant prostate ...
Scottish Medicines Consortium (SMC) has recommended Fabhalta® (iptacopan) as monotherapy for adults with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia and used under the ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback